Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade RB Patel, R Hernandez, P Carlson, J Grudzinski, AM Bates, ... Science translational medicine 13 (602), eabb3631, 2021 | 127 | 2021 |
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy JC Jagodinsky, WJ Jin, AM Bates, R Hernandez, JJ Grudzinski, IR Marsh, ... Theranostics 11 (13), 6120, 2021 | 49 | 2021 |
Direct reaction measurements using GODDESS SD Pain, A Ratkiewicz, T Baugher, M Febbraro, A Lepailleur, ... Physics Procedia 90, 455-462, 2017 | 30 | 2017 |
Preclinical characterization of 86/90Y-NM600 in a variety of murine and human cancer tumor models JJ Grudzinski, R Hernandez, I Marsh, RB Patel, E Aluicio-Sarduy, J Engle, ... Journal of Nuclear Medicine 60 (11), 1622-1628, 2019 | 28 | 2019 |
Preclinical pharmacokinetics and dosimetry studies of 124I/131I-CLR1404 for treatment of pediatric solid tumors in murine xenograft models IR Marsh, J Grudzinski, DC Baiu, A Besemer, R Hernandez, JJ Jeffery, ... Journal of Nuclear Medicine 60 (10), 1414-1420, 2019 | 27 | 2019 |
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative … K Magee, IR Marsh, MM Turek, J Grudzinski, E Aluicio-Sarduy, JW Engle, ... PLoS One 16 (8), e0255798, 2021 | 20 | 2021 |
Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog DC Baiu, IR Marsh, AE Boruch, A Shahi, S Bhattacharya, JJ Jeffery, ... Journal of Nuclear Medicine 59 (2), 244-250, 2018 | 20 | 2018 |
CLR 125 Auger electrons for the targeted radiotherapy of triple-negative breast cancer J Grudzinski, I Marsh, B Titz, J Jeffery, M Longino, K Kozak, K Lange, ... Cancer Biotherapy & Radiopharmaceuticals 33 (3), 87-95, 2018 | 19 | 2018 |
Murine-specific internal dosimetry for preclinical investigations of imaging and therapeutic agents B Bednarz, J Grudzinski, I Marsh, A Besemer, D Baiu, J Weichert, M Otto Health physics 114 (4), 450-459, 2018 | 18 | 2018 |
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors HK Potluri, CA Ferreira, J Grudzinski, C Massey, E Aluicio-Sarduy, ... Journal for Immunotherapy of Cancer 10 (8), 2022 | 14 | 2022 |
Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain PA Clark, RN Sriramaneni, AM Bates, WJ Jin, JC Jagodinsky, ... Radiation research 195 (6), 522-540, 2021 | 12 | 2021 |
Collectivity of states in SR Lesher, C Casarella, A Aprahamian, BP Crider, R Ikeyama, IR Marsh, ... Physical Review C 91 (5), 054317, 2015 | 12 | 2015 |
Lifetime measurements of low-spin negative-parity levels in SR Lesher, C Casarella, A Aprahamian, LM Robledo, BP Crider, ... Physical Review C 95 (6), 064309, 2017 | 11 | 2017 |
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination PM Carlson, RB Patel, J Birstler, M Rodriquez, C Sun, AK Erbe, AM Bates, ... Journal for immunotherapy of cancer 11 (1), 2023 | 5 | 2023 |
Targeting of head and neck cancer by radioiodinated CLR1404 in murine xenograft tumor models with partial volume corrected theranostic dosimetry IR Marsh, C Li, J Grudzinski, J Jeffery, C Longhurst, DP Adam, ... Cancer Biotherapy & Radiopharmaceuticals 38 (7), 458-467, 2023 | 1 | 2023 |
Inelastic Neutron Scattering on 160Gd SR Lesher, C Casarella, BP Crider, R Ikeyama, I Marsh, EE Peters, ... EPJ Web of Conferences 66, 02063, 2014 | 1 | 2014 |
Treatment Planning for Immunomodulatory Radiopharmaceutical Therapy IR Marsh The University of Wisconsin-Madison, 2021 | | 2021 |
Transfer Reactions with 134Xe SD Pain, KA Chipps, M Febbraro, I Marsh, MS Smith, RL Varner, ... Fission and Properties of Neutron-Rich Nuclei: Proceedings of the Sixth …, 2018 | | 2018 |